NEK2 and nasopharyngeal carcinoma: The results showed a strong positive correlation between NEK2 expression and clinical stages of NPC, and the advanced clinical stages (stage III‐IV) had a significantly higher positive percentage of NEK2 expression than that in the early stages of NPC (P = 0.034) (Table 2).